proxyvotesnow.com

Home › Companies › SILK ROAD MEDICAL INC. › 2024-2025

SILK ROAD MEDICAL INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated 02 October 2026.

  • 7Reported items
  • 191Asset managers
  • 655Fund votes
  • 2024-09-05Meeting date

Proxy season: 2023-2024 2024-2025

Explore SILK ROAD MEDICAL INC. in the interactive database Compare manager voting policies

How asset managers voted at the SILK ROAD MEDICAL INC. 2024-2025 meeting

Each item below shows how the 191 asset managers that disclosed a SILK ROAD MEDICAL INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of SILK ROAD MEDICAL INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Silk Road to its named executive officers in connection with the merger contemplated by the merger agreement.

SECTION 14A SAY-ON-PAY VOTES

Combines 5 wordings of this item as funds reported it.

75% fund support · no official result

FOR 75%AGAINST 25%

The 182 asset managers below cast 75% of the shares they voted on this item FOR (22,847,996 for, 7,759,686 against).

FOR: 22,847,996 (74.6%)AGAINST: 7,759,686 (25.3%)ABSTAIN: 35,687 (0.1%)
Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Silk Road to” at SILK ROAD MEDICAL INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock3,231,57010,263 00For
Vanguard2,996,6100 00For
Fidelity2,451,1390 00For
State Street1,189,4020 00For
TimesSquare Capital Management, LLC955,1090 00For
GEODE CAPITAL MANAGEMENT, LLC910,1790 00For
DE Shaw880,6070 00For
NEXPOINT ASSET MANAGEMENT, L.P.0810,480 00Against
NEXPOINT FUNDS I0810,480 00Against
WATER ISLAND CAPITAL LLC756,9790 00For
Nuveen0742,612 00Against
TIAA0740,307 00Against
Magnetar Financial LLC724,5520 00For
ARBITRAGE FUNDS694,0000 00For
Gabelli691,0620 00For
BAMCO INC /NY/0673,438 00Against
Woodline Partners LP667,8300 00For
Charles Schwab0639,391 00Against
KENNEDY CAPITAL MANAGEMENT LLC628,8260 00For
Investment Managers Series Trust II615,53110,000 00For
Two Sigma616,1630 00For
ArrowMark Colorado Holdings LLC0604,020 00Against
Cinctive Capital Management LP565,2580 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)0553,710 00Against
BALYASNY ASSET MANAGEMENT L.P.0512,445 00Against

Showing the 25 largest of 182 asset managers. See all 182 in the interactive database.

2. To adopt the Agreement and Plan of Merger, dated June 17, 2024 (as it may be amended, modified, supplemented or waived from time to time), by and among Silk Road, Boston Scientific Corporation and Seminole Merger Sub, Inc. (the "merger agreement" ).

EXTRAORDINARY TRANSACTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.5%

The 61 asset managers below cast 100% of the shares they voted on this item FOR (11,845,952 for, 0 against).

FOR: 11,845,952 (99.5%)ABSTAIN: 54,890 (0.5%)
Largest asset managers voting on “To adopt the Agreement and Plan of Merger, dated June 17, 2024 (as it may be amended, modified, supplemented o” at SILK ROAD MEDICAL INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,864,5640 00For
BlackRock1,771,3470 00For
Fidelity860,2840 00For
NEXPOINT FUNDS I810,4800 00For
TIAA740,3070 00For
ARBITRAGE FUNDS694,0000 00For
Investment Managers Series Trust II625,5310 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)553,7100 00For
MERGER FUND418,0790 00For
Charles Schwab319,6700 00For
MERIDIAN FUND INC316,7750 00For
State Street197,5100 00For
Equitable135,6450 54,8900For
FIRST EAGLE FUNDS188,8210 00For
Gabelli155,3920 00For
Jackson National154,0680 00For
Virtus95,9370 00For
AQR94,9600 00For
AMG FUNDS94,0500 00For
QUANTITATIVE MASTER SERIES LLC78,2120 00For
GDL FUND77,1040 00For
New York Life67,2380 00For
ALTSHARES TRUST62,9790 00For
Invesco60,2880 00For
Lincoln Financial52,8310 00For

Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.

3. To adjourn the Special Meating, from time to time, to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the Special Meeting.

CORPORATE GOVERNANCE

85% fund support · no official result

FOR 84%AGAINST 15%

The 37 asset managers below cast 85% of the shares they voted on this item FOR (6,108,252 for, 1,085,861 against).

FOR: 6,108,252 (84.3%)AGAINST: 1,085,861 (15.0%)ABSTAIN: 54,890 (0.8%)
Largest asset managers voting on “To adjourn the Special Meating, from time to time, to a later date or dates, if necessary or appropriate, incl” at SILK ROAD MEDICAL INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard2,864,5640 00For
Fidelity17,958842,326 00Against
TIAA740,3070 00For
Investment Managers Series Trust II615,5310 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)553,7100 00For
MERGER FUND418,0790 00For
State Street579196,931 00Against
Equitable135,6450 54,8900For
FIRST EAGLE FUNDS188,8210 00For
Virtus95,9370 00For
AQR94,9600 00For
New York Life67,2380 00For
Invesco60,2880 00For
Lincoln Financial21,63131,200 00Against
Guggenheim41,3440 00For
First Trust22,5550 00For
AIG/SunAmerica21,1040 00For
Northern Trust18,1600 00For
Goldman Sachs17,6100 00For
ProShares15,6610 00For
Pacific Life13,4440 00For
Voya13,0290 00For
T. Rowe Price012,700 00Against
Brighthouse12,6510 00For
Principal11,8470 00For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

4. TO ADJOURN THE SPECIAL MEETING, FROM TIME TO TIME, TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, INCLUDING TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES TO ADOPT THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING.

CORPORATE GOVERNANCE

100% fund support · no official result

FOR 99.7%

The 26 asset managers below cast 100% of the shares they voted on this item FOR (4,642,185 for, 0 against).

FOR: 4,642,185 (99.8%)ABSTAIN: 9,629 (0.2%)
Largest asset managers voting on “TO ADJOURN THE SPECIAL MEETING, FROM TIME TO TIME, TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, INCL” at SILK ROAD MEDICAL INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock1,771,3470 00For
NEXPOINT FUNDS I810,4800 00For
ARBITRAGE FUNDS694,0000 00For
Charles Schwab319,6700 00For
MERIDIAN FUND INC316,7750 00For
Gabelli155,3920 00For
Jackson National154,0680 00For
AMG FUNDS94,0500 00For
QUANTITATIVE MASTER SERIES LLC78,2120 00For
GDL FUND77,1040 00For
ALTSHARES TRUST62,9790 00For
Global X30,6060 00For
John Hancock14,5860 00For
MASTER INVESTMENT PORTFOLIO11,9510 00For
Investment Managers Series Trust II10,0000 00For
Brighthouse00 9,6290Abstain
Neuberger Berman9,5700 00For
Exchange Place Advisors Trust8,2850 00For
Bridge Builder Trust7,6080 00For
SEI7,6000 00For
Comstock Funds, Inc.3,0000 00For
Tema ETF Trust2,8790 00For
GPS Funds I1,2480 00For
Nationwide4640 00For
WILSHIRE MUTUAL FUNDS INC1750 00For

Showing the 25 largest of 26 asset managers. See all 26 in the interactive database.

5. Advisory Vote on Golden Parachutes

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (174,880 for, 0 against).

FOR: 174,880 (100.0%)
Largest asset managers voting on “Advisory Vote on Golden Parachutes” at SILK ROAD MEDICAL INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
GuideStone139,8700 00For
JPMorgan33,0990 00For
HC CAPITAL TRUST1,9110 00For

6. Adjourn Meeting

CORPORATE GOVERNANCE

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (141,781 for, 0 against).

FOR: 141,781 (100.0%)
Largest asset managers voting on “Adjourn Meeting” at SILK ROAD MEDICAL INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
GuideStone139,8700 00For
HC CAPITAL TRUST1,9110 00For

7. Approve Merger Agreement

EXTRAORDINARY TRANSACTIONS

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (141,781 for, 0 against).

FOR: 141,781 (100.0%)
Largest asset managers voting on “Approve Merger Agreement” at SILK ROAD MEDICAL INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
GuideStone139,8700 00For
HC CAPITAL TRUST1,9110 00For

Largest SILK ROAD MEDICAL INC. shareholders voting in 2024-2025

Ranked by the number of SILK ROAD MEDICAL INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 40,612,481 shares outstanding at the time of that meeting.

Top SILK ROAD MEDICAL INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 7.98%
2Vanguard 7.38%
3Fidelity 6.04%
4State Street 2.93%
5TimesSquare Capital Management, LLC 2.35%
6GEODE CAPITAL MANAGEMENT, LLC 2.24%
7DE Shaw 2.17%
8NEXPOINT ASSET MANAGEMENT, L.P. 2.00%
9NEXPOINT FUNDS I 2.00%
10WATER ISLAND CAPITAL LLC 1.86%

Reported SILK ROAD MEDICAL INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

SILK ROAD MEDICAL INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Norges Bank 0.91% 13F

Percentages above are of 40,612,481 shares outstanding, as reported by SILK ROAD MEDICAL INC. on its Form 10-Q dated 2024-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SILK ROAD MEDICAL INC.’s 10-Q dated 2024-06-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At SILK ROAD MEDICAL INC.'s shareholder meeting held 2024-09-05, in the 2024-2025 proxy season, 191 asset managers reported how they voted in their SEC Form N-PX filings, covering 655 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on a non-binding, advisory basis, the compensation that will or may become payable… — the reporting funds cast 75% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

SILK ROAD MEDICAL INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).